Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Volunteers Diabetes Mellitus, Type 2”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02451722
What this trial is testing

Evaluation of Pressure Distribution of Kyboot Shoes in Comparison to Other Foot Wear

Who this might be right for
Diabetes Mellitus Type 2Sensory NeuropathyFoot Ulcer, Diabetic
Sheba Medical Center 21
Early research (Phase 1)Study completedNCT01819922
What this trial is testing

Effect Of Single-Dose PF-05175157 On Metabolic And Cardiopulmonary Parameters

Who this might be right for
Healthy
Pfizer 12
Early research (Phase 1)Study completedNCT00910923
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-38431055 in Healthy Male Volunteers

Who this might be right for
Diabetes Mellitus, Type 2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 37
Early research (Phase 1)Ended earlyNCT01372163
What this trial is testing

PF-05190457 In Healthy Volunteers And Type-2 Diabetic Patients

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 35
Early research (Phase 1)Study completedNCT02002611
What this trial is testing

Drug-drug Interaction Study(Lobeglitazone, Warfarin)

Who this might be right for
Type 2 Diabetes Mellitus
Chong Kun Dang Pharmaceutical 24
Testing effectiveness (Phase 2)Study completedNCT01248364
What this trial is testing

Determine Acute (After First Dose) and Chronic (After 28 Days) Effects of Empagliflozin (BI 10773) on Pre and Postprandial Glucose Homeostasis in Patients With Impaired Glucose Tolerance and Type 2 Diabetes Mellitus and Healthy Subjects

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 91
Testing effectiveness (Phase 2)Study completedNCT06549556
What this trial is testing

The Value of Using Colostrum Supplements on the Physical Performance and Cognitive Function in Healthy Subjects and Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Al-Rasheed University College 100
Early research (Phase 1)Study completedNCT03115099
What this trial is testing

LY3325656 in Healthy Participants and Participants With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 80
Early research (Phase 1)Study completedNCT04513704
What this trial is testing

A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different Times

Who this might be right for
Healthy Volunteers Type 2 Diabetes
Novo Nordisk A/S 156
Early research (Phase 1)Study completedNCT00976729
What this trial is testing

NOX-E36 First-in-Human (FIH) Study

Who this might be right for
Chronic Inflammatory DiseasesType 2 Diabetes MellitusSystemic Lupus Erythematosus
TME Pharma AG 72
Early research (Phase 1)Study completedNCT03864432
What this trial is testing

An Ascending Dose, Single/Multiple Dosing, Food Effect Clinical Trial to Evaluate Pharmacokinetics, Safety and Tolerability in Healthy Subjects After Oral Administration of Gemigliptin (Phase I)

Who this might be right for
Type 2 Diabetes Mellitus
LG Chem 48
Early research (Phase 1)Study completedNCT00770302
What this trial is testing

Assess Pharmacokinetics, Safety and Tolerability in Healthy Chinese Volunteers After Oral Doses of Saxagliptin

Who this might be right for
Type 2 Diabetes
AstraZeneca 34
Not applicableUnknownNCT05461560
What this trial is testing

Effects of Seaweed Extract on Blood Glucose Response to Sucrose

Who this might be right for
Glucose IntoleranceDiabetes Mellitus, Type 2Healthy Diet+1 more
University College Dublin 20
Early research (Phase 1)Study completedNCT03138356
What this trial is testing

Bioequivalence Study of Combination Tablets of Saxagliptin / Dapagliflozin / Metformin XR (Extended-release) and Dapagliflozin / Metformin XR Relative to Individual Components in Healthy Subjects

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 126
Early research (Phase 1)Study completedNCT05227196
What this trial is testing

A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy People

Who this might be right for
Healthy VolunteersType 2 Diabetes
Novo Nordisk A/S 546
Early research (Phase 1)Study completedNCT02627027
What this trial is testing

A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers

Who this might be right for
Diabetes Mellitus, Type II
Chong Kun Dang Pharmaceutical 26
Early research (Phase 1)Study completedNCT01068743
What this trial is testing

Bioequivalence Study of Fixed Dose Combination of 2.5 mg Saxagliptin/850 mg Metformin Tablet Relative to 2.5 mg Onglyza and 850 mg Glucophage Tablets Co-Administered

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 24
Early research (Phase 1)Study completedNCT01002807
What this trial is testing

Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
AstraZeneca 15
Early research (Phase 1)Study completedNCT01538511
What this trial is testing

Insulin Profile of Biphasic Insulin Aspart 70 to That of Biphasic Insulin Aspart 30 in Healthy Volunteers

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 59
Early research (Phase 1)Study completedNCT00930865
What this trial is testing

Study to Evaluate the Potential Pharmacokinetic Interaction and Pharmacodynamic Effects on Renal Parameters of Bumetanide (1mg) and Dapagliflozin (10 mg) When Co-administered in Healthy Subjects

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 42
Next Page